Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies

IM Rouzine, G Rozhnova - Communications medicine, 2023 - nature.com
Once the first SARS-CoV-2 vaccine became available, mass vaccination was the main pillar
of the public health response to the COVID-19 pandemic. It was very effective in reducing …

Roadmap for achieving universal antiretroviral treatment

S Sokhela, S Lalla-Edward, MJ Siedner… - Annual review of …, 2023 - annualreviews.org
Modern antiretroviral therapy safely, potently, and durably suppresses human
immunodeficiency virus (HIV) that, if left untreated, predictably causes acquired …

Darwin review: the evolution of virulence in human pathogens

S Gupta - Proceedings of the Royal Society B, 2024 - royalsocietypublishing.org
By definition, all pathogens cause some level of harm to their hosts. If this harm occurs while
the pathogen is transmitting, it can negatively affect the pathogen's fitness by shortening the …

Do pathogens always evolve to be less virulent? The virulence–transmission trade-off in light of the COVID-19 pandemic

Á Kun, AG Hubai, A Král, J Mokos, BÁ Mikulecz… - Biologia futura, 2023 - Springer
The direction the evolution of virulence takes in connection with any pathogen is a long-
standing question. Formerly, it was theorized that pathogens should always evolve to be …

High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana

PT Mokgethi, WT Choga, D Maruapula… - Frontiers in …, 2024 - frontiersin.org
Background Approximately 30,000 non-citizens are living with HIV in Botswana, all of whom
as of 2020 are eligible to receive free antiretroviral treatment (ART) within the country. We …

Identification of a HIV-1 circulating BF1 recombinant form (CRF75_BF1) of Brazilian origin that also circulates in Southwestern Europe

J Bacqué, E Delgado, H Gil, S Ibarra, S Benito… - Frontiers in …, 2023 - frontiersin.org
Introduction The high recombinogenic potential of HIV-1 has resulted in the generation of
countless unique recombinant forms (URFs) and around 120 reported circulating …

Global associations of key populations with HIV-1 recombinants: a systematic review, global survey, and individual participant data meta-analysis

N Nchinda, R Elangovan, J Yun… - Frontiers in Public …, 2023 - frontiersin.org
Introduction Global HIV infections due to HIV-1 recombinants are increasing and impede
prevention and treatment efforts. Key populations suffer most new HIV infections, but their …

Scorpion-shaped zinc porphyrins as tetrafunctional TAR RNA predators and HIV-1 reverse transcriptase inhibitors

R Yang, XD Bi, Y Li, M Liu, MQ Hu, LM Zhao… - Inorganic …, 2022 - ACS Publications
HIV-1 reverse transcriptase (RT) inhibitors are fundamental to the discovery and
development of anti-HIV drugs. Their main target is RT, and only a tiny number of them can …

[HTML][HTML] Public Discourse, User Reactions, and Conspiracy Theories on the X Platform About HIV Vaccines: Data Mining and Content Analysis

JM Zhang, Y Wang, M Mouton, J Zhang… - Journal of Medical Internet …, 2024 - jmir.org
Background The initiation of clinical trials for messenger RNA (mRNA) HIV vaccines in early
2022 revived public discussion on HIV vaccines after 3 decades of unsuccessful research …

A New HIV-1 K28E32-Reverse Transcriptase Variant Associated with the Rapid Expansion of CRF07_BC among Men Who Have Sex with Men

J Han, YH Zhou, Y Ma, G Zhu, D Zhang… - Microbiology …, 2022 - Am Soc Microbiol
ABSTRACT HIV-1 CRF07_BC originated among injection drug users (IDUs) in China. After
diffusing into men who have sex with men (MSM), CRF07_BC has shown a rapid expansion …